ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant FSH Injections Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-39X16523
Home | Market Reports | Health| Reproductive Health
Global Recombinant FSH Injections Market Research Report 2024
BUY CHAPTERS

Global Recombinant FSH Injections Market Research Report 2025

Code: QYRE-Auto-39X16523
Report
September 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Gonal-F (Merck)
Follistim (Organon)
Bravelle (Ferring)
Menopur (Ferring)
Fostimon (IBSA)
Puregon (Organon)
BEMFOLA (Gedeon Richter)
Follitrope (LG Chem)
GenSci

Recombinant FSH Injections Market

The global market for Recombinant FSH Injections was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Follicle Stimulating Hormone (FSH) injections are pharmaceutical preparations containing the hormone FSH, a crucial component in the regulation of reproductive processes. FSH is produced by the pituitary gland and plays a key role in the stimulation of ovarian follicles in females and sperm production in males. FSH injections are commonly used in assisted reproductive technologies, such as in vitro fertilization (IVF), to enhance the development and maturation of multiple follicles in the ovaries. In fertility treatments, these injections help regulate and stimulate the ovaries to produce more eggs, increasing the chances of successful fertilization and pregnancy.
Human follicle stimulating hormone (FSH) includes urinary human follicle stimulating hormone (uFSH) and recombinant FSH (rFSH). According to expert consensus, recombinant follicle-stimulating hormone is available in two dosage forms: powder injection and water injection.
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant FSH Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant FSH Injections.
The Recombinant FSH Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant FSH Injections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant FSH Injections manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant FSH Injections Market Report

Report Metric Details
Report Name Recombinant FSH Injections Market
Segment by Type
  • Powder
  • Liquid
Segment by Application
  • IVF and Embryo Transfer
  • Infertility Treatment
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Gonal-F (Merck), Follistim (Organon), Bravelle (Ferring), Menopur (Ferring), Fostimon (IBSA), Puregon (Organon), BEMFOLA (Gedeon Richter), Follitrope (LG Chem), GenSci
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant FSH Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant FSH Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Recombinant FSH Injections Market report?

Ans: The main players in the Recombinant FSH Injections Market are Gonal-F (Merck), Follistim (Organon), Bravelle (Ferring), Menopur (Ferring), Fostimon (IBSA), Puregon (Organon), BEMFOLA (Gedeon Richter), Follitrope (LG Chem), GenSci

What are the Application segmentation covered in the Recombinant FSH Injections Market report?

Ans: The Applications covered in the Recombinant FSH Injections Market report are IVF and Embryo Transfer, Infertility Treatment

What are the Type segmentation covered in the Recombinant FSH Injections Market report?

Ans: The Types covered in the Recombinant FSH Injections Market report are Powder, Liquid

1 Recombinant FSH Injections Market Overview
1.1 Product Definition
1.2 Recombinant FSH Injections by Type
1.2.1 Global Recombinant FSH Injections Market Value Comparison by Type (2024 VS 2031)
1.2.2 Powder
1.2.3 Liquid
1.3 Recombinant FSH Injections by Application
1.3.1 Global Recombinant FSH Injections Market Value by Application (2024 VS 2031)
1.3.2 IVF and Embryo Transfer
1.3.3 Infertility Treatment
1.4 Global Recombinant FSH Injections Market Size Estimates and Forecasts
1.4.1 Global Recombinant FSH Injections Revenue 2020-2031
1.4.2 Global Recombinant FSH Injections Sales 2020-2031
1.4.3 Global Recombinant FSH Injections Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant FSH Injections Market Competition by Manufacturers
2.1 Global Recombinant FSH Injections Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant FSH Injections Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant FSH Injections Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant FSH Injections, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant FSH Injections, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant FSH Injections, Product Type & Application
2.7 Global Key Manufacturers of Recombinant FSH Injections, Date of Enter into This Industry
2.8 Global Recombinant FSH Injections Market Competitive Situation and Trends
2.8.1 Global Recombinant FSH Injections Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant FSH Injections Players Market Share by Revenue
2.8.3 Global Recombinant FSH Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant FSH Injections Market Scenario by Region
3.1 Global Recombinant FSH Injections Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant FSH Injections Sales by Region: 2020-2031
3.2.1 Global Recombinant FSH Injections Sales by Region: 2020-2025
3.2.2 Global Recombinant FSH Injections Sales by Region: 2026-2031
3.3 Global Recombinant FSH Injections Revenue by Region: 2020-2031
3.3.1 Global Recombinant FSH Injections Revenue by Region: 2020-2025
3.3.2 Global Recombinant FSH Injections Revenue by Region: 2026-2031
3.4 North America Recombinant FSH Injections Market Facts & Figures by Country
3.4.1 North America Recombinant FSH Injections Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant FSH Injections Sales by Country (2020-2031)
3.4.3 North America Recombinant FSH Injections Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant FSH Injections Market Facts & Figures by Country
3.5.1 Europe Recombinant FSH Injections Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant FSH Injections Sales by Country (2020-2031)
3.5.3 Europe Recombinant FSH Injections Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant FSH Injections Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant FSH Injections Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant FSH Injections Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant FSH Injections Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant FSH Injections Market Facts & Figures by Country
3.7.1 Latin America Recombinant FSH Injections Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant FSH Injections Sales by Country (2020-2031)
3.7.3 Latin America Recombinant FSH Injections Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant FSH Injections Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant FSH Injections Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant FSH Injections Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant FSH Injections Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant FSH Injections Sales by Type (2020-2031)
4.1.1 Global Recombinant FSH Injections Sales by Type (2020-2025)
4.1.2 Global Recombinant FSH Injections Sales by Type (2026-2031)
4.1.3 Global Recombinant FSH Injections Sales Market Share by Type (2020-2031)
4.2 Global Recombinant FSH Injections Revenue by Type (2020-2031)
4.2.1 Global Recombinant FSH Injections Revenue by Type (2020-2025)
4.2.2 Global Recombinant FSH Injections Revenue by Type (2026-2031)
4.2.3 Global Recombinant FSH Injections Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant FSH Injections Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant FSH Injections Sales by Application (2020-2031)
5.1.1 Global Recombinant FSH Injections Sales by Application (2020-2025)
5.1.2 Global Recombinant FSH Injections Sales by Application (2026-2031)
5.1.3 Global Recombinant FSH Injections Sales Market Share by Application (2020-2031)
5.2 Global Recombinant FSH Injections Revenue by Application (2020-2031)
5.2.1 Global Recombinant FSH Injections Revenue by Application (2020-2025)
5.2.2 Global Recombinant FSH Injections Revenue by Application (2026-2031)
5.2.3 Global Recombinant FSH Injections Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant FSH Injections Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Gonal-F (Merck)
6.1.1 Gonal-F (Merck) Company Information
6.1.2 Gonal-F (Merck) Description and Business Overview
6.1.3 Gonal-F (Merck) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Gonal-F (Merck) Recombinant FSH Injections Product Portfolio
6.1.5 Gonal-F (Merck) Recent Developments/Updates
6.2 Follistim (Organon)
6.2.1 Follistim (Organon) Company Information
6.2.2 Follistim (Organon) Description and Business Overview
6.2.3 Follistim (Organon) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Follistim (Organon) Recombinant FSH Injections Product Portfolio
6.2.5 Follistim (Organon) Recent Developments/Updates
6.3 Bravelle (Ferring)
6.3.1 Bravelle (Ferring) Company Information
6.3.2 Bravelle (Ferring) Description and Business Overview
6.3.3 Bravelle (Ferring) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bravelle (Ferring) Recombinant FSH Injections Product Portfolio
6.3.5 Bravelle (Ferring) Recent Developments/Updates
6.4 Menopur (Ferring)
6.4.1 Menopur (Ferring) Company Information
6.4.2 Menopur (Ferring) Description and Business Overview
6.4.3 Menopur (Ferring) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Menopur (Ferring) Recombinant FSH Injections Product Portfolio
6.4.5 Menopur (Ferring) Recent Developments/Updates
6.5 Fostimon (IBSA)
6.5.1 Fostimon (IBSA) Company Information
6.5.2 Fostimon (IBSA) Description and Business Overview
6.5.3 Fostimon (IBSA) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Fostimon (IBSA) Recombinant FSH Injections Product Portfolio
6.5.5 Fostimon (IBSA) Recent Developments/Updates
6.6 Puregon (Organon)
6.6.1 Puregon (Organon) Company Information
6.6.2 Puregon (Organon) Description and Business Overview
6.6.3 Puregon (Organon) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Puregon (Organon) Recombinant FSH Injections Product Portfolio
6.6.5 Puregon (Organon) Recent Developments/Updates
6.7 BEMFOLA (Gedeon Richter)
6.7.1 BEMFOLA (Gedeon Richter) Company Information
6.7.2 BEMFOLA (Gedeon Richter) Description and Business Overview
6.7.3 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.7.4 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product Portfolio
6.7.5 BEMFOLA (Gedeon Richter) Recent Developments/Updates
6.8 Follitrope (LG Chem)
6.8.1 Follitrope (LG Chem) Company Information
6.8.2 Follitrope (LG Chem) Description and Business Overview
6.8.3 Follitrope (LG Chem) Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Follitrope (LG Chem) Recombinant FSH Injections Product Portfolio
6.8.5 Follitrope (LG Chem) Recent Developments/Updates
6.9 GenSci
6.9.1 GenSci Company Information
6.9.2 GenSci Description and Business Overview
6.9.3 GenSci Recombinant FSH Injections Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GenSci Recombinant FSH Injections Product Portfolio
6.9.5 GenSci Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant FSH Injections Industry Chain Analysis
7.2 Recombinant FSH Injections Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant FSH Injections Production Mode & Process Analysis
7.4 Recombinant FSH Injections Sales and Marketing
7.4.1 Recombinant FSH Injections Sales Channels
7.4.2 Recombinant FSH Injections Distributors
7.5 Recombinant FSH Injections Customer Analysis
8 Recombinant FSH Injections Market Dynamics
8.1 Recombinant FSH Injections Industry Trends
8.2 Recombinant FSH Injections Market Drivers
8.3 Recombinant FSH Injections Market Challenges
8.4 Recombinant FSH Injections Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Gonal-F (Merck)
Follistim (Organon)
Bravelle (Ferring)
Menopur (Ferring)
Fostimon (IBSA)
Puregon (Organon)
BEMFOLA (Gedeon Richter)
Follitrope (LG Chem)
GenSci
List of Tables
 Table 1. Global Recombinant FSH Injections Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant FSH Injections Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant FSH Injections Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant FSH Injections Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant FSH Injections Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant FSH Injections Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant FSH Injections Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant FSH Injections Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant FSH Injections, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant FSH Injections, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant FSH Injections, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant FSH Injections, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant FSH Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant FSH Injections as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant FSH Injections Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant FSH Injections Sales by Region (2020-2025) & (K Units)
 Table 18. Global Recombinant FSH Injections Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant FSH Injections Sales by Region (2026-2031) & (K Units)
 Table 20. Global Recombinant FSH Injections Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant FSH Injections Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant FSH Injections Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant FSH Injections Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant FSH Injections Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant FSH Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant FSH Injections Sales by Country (2020-2025) & (K Units)
 Table 27. North America Recombinant FSH Injections Sales by Country (2026-2031) & (K Units)
 Table 28. North America Recombinant FSH Injections Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant FSH Injections Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant FSH Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant FSH Injections Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Recombinant FSH Injections Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Recombinant FSH Injections Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant FSH Injections Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant FSH Injections Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant FSH Injections Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Recombinant FSH Injections Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Recombinant FSH Injections Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant FSH Injections Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant FSH Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant FSH Injections Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Recombinant FSH Injections Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Recombinant FSH Injections Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant FSH Injections Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant FSH Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant FSH Injections Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Recombinant FSH Injections Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Recombinant FSH Injections Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant FSH Injections Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant FSH Injections Sales (K Units) by Type (2020-2025)
 Table 51. Global Recombinant FSH Injections Sales (K Units) by Type (2026-2031)
 Table 52. Global Recombinant FSH Injections Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant FSH Injections Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant FSH Injections Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant FSH Injections Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant FSH Injections Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant FSH Injections Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant FSH Injections Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Recombinant FSH Injections Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Recombinant FSH Injections Sales (K Units) by Application (2020-2025)
 Table 61. Global Recombinant FSH Injections Sales (K Units) by Application (2026-2031)
 Table 62. Global Recombinant FSH Injections Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant FSH Injections Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant FSH Injections Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant FSH Injections Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant FSH Injections Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant FSH Injections Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant FSH Injections Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Recombinant FSH Injections Price (US$/Unit) by Application (2026-2031)
 Table 70. Gonal-F (Merck) Company Information
 Table 71. Gonal-F (Merck) Description and Business Overview
 Table 72. Gonal-F (Merck) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Gonal-F (Merck) Recombinant FSH Injections Product
 Table 74. Gonal-F (Merck) Recent Developments/Updates
 Table 75. Follistim (Organon) Company Information
 Table 76. Follistim (Organon) Description and Business Overview
 Table 77. Follistim (Organon) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Follistim (Organon) Recombinant FSH Injections Product
 Table 79. Follistim (Organon) Recent Developments/Updates
 Table 80. Bravelle (Ferring) Company Information
 Table 81. Bravelle (Ferring) Description and Business Overview
 Table 82. Bravelle (Ferring) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Bravelle (Ferring) Recombinant FSH Injections Product
 Table 84. Bravelle (Ferring) Recent Developments/Updates
 Table 85. Menopur (Ferring) Company Information
 Table 86. Menopur (Ferring) Description and Business Overview
 Table 87. Menopur (Ferring) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Menopur (Ferring) Recombinant FSH Injections Product
 Table 89. Menopur (Ferring) Recent Developments/Updates
 Table 90. Fostimon (IBSA) Company Information
 Table 91. Fostimon (IBSA) Description and Business Overview
 Table 92. Fostimon (IBSA) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Fostimon (IBSA) Recombinant FSH Injections Product
 Table 94. Fostimon (IBSA) Recent Developments/Updates
 Table 95. Puregon (Organon) Company Information
 Table 96. Puregon (Organon) Description and Business Overview
 Table 97. Puregon (Organon) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Puregon (Organon) Recombinant FSH Injections Product
 Table 99. Puregon (Organon) Recent Developments/Updates
 Table 100. BEMFOLA (Gedeon Richter) Company Information
 Table 101. BEMFOLA (Gedeon Richter) Description and Business Overview
 Table 102. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product
 Table 104. BEMFOLA (Gedeon Richter) Recent Developments/Updates
 Table 105. Follitrope (LG Chem) Company Information
 Table 106. Follitrope (LG Chem) Description and Business Overview
 Table 107. Follitrope (LG Chem) Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Follitrope (LG Chem) Recombinant FSH Injections Product
 Table 109. Follitrope (LG Chem) Recent Developments/Updates
 Table 110. GenSci Company Information
 Table 111. GenSci Description and Business Overview
 Table 112. GenSci Recombinant FSH Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. GenSci Recombinant FSH Injections Product
 Table 114. GenSci Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Recombinant FSH Injections Distributors List
 Table 118. Recombinant FSH Injections Customers List
 Table 119. Recombinant FSH Injections Market Trends
 Table 120. Recombinant FSH Injections Market Drivers
 Table 121. Recombinant FSH Injections Market Challenges
 Table 122. Recombinant FSH Injections Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant FSH Injections
 Figure 2. Global Recombinant FSH Injections Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant FSH Injections Market Share by Type: 2024 & 2031
 Figure 4. Powder Product Picture
 Figure 5. Liquid Product Picture
 Figure 6. Global Recombinant FSH Injections Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Recombinant FSH Injections Market Share by Application: 2024 & 2031
 Figure 8. IVF and Embryo Transfer
 Figure 9. Infertility Treatment
 Figure 10. Global Recombinant FSH Injections Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Recombinant FSH Injections Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Recombinant FSH Injections Sales (2020-2031) & (K Units)
 Figure 13. Global Recombinant FSH Injections Average Price (US$/Unit) & (2020-2031)
 Figure 14. Recombinant FSH Injections Report Years Considered
 Figure 15. Recombinant FSH Injections Sales Share by Manufacturers in 2024
 Figure 16. Global Recombinant FSH Injections Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Recombinant FSH Injections Players: Market Share by Revenue in Recombinant FSH Injections in 2024
 Figure 18. Recombinant FSH Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Recombinant FSH Injections Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Recombinant FSH Injections Sales Market Share by Country (2020-2031)
 Figure 21. North America Recombinant FSH Injections Revenue Market Share by Country (2020-2031)
 Figure 22. United States Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Recombinant FSH Injections Sales Market Share by Country (2020-2031)
 Figure 25. Europe Recombinant FSH Injections Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Recombinant FSH Injections Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Recombinant FSH Injections Revenue Market Share by Region (2020-2031)
 Figure 33. China Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Recombinant FSH Injections Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Recombinant FSH Injections Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Recombinant FSH Injections Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Recombinant FSH Injections Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Recombinant FSH Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Recombinant FSH Injections by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Recombinant FSH Injections by Type (2020-2031)
 Figure 52. Global Recombinant FSH Injections Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Recombinant FSH Injections by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Recombinant FSH Injections by Application (2020-2031)
 Figure 55. Global Recombinant FSH Injections Price (US$/Unit) by Application (2020-2031)
 Figure 56. Recombinant FSH Injections Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Follicle Stimulating Hormone FSH Injections Market Research Report 2024
Global Follicle Stimulating Hormone Market Research Report 2025
Recombinant Human Follicle stimulating Hormone Market
Recombinant Follicle Stimulating Hormone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Injectable Fertility Medications Market Research Report 2024
Global Recombinant Human Follicle Stimulating Hormone Injection Market Research Report 2024
Global Injectable IVF Medications Market Research Report 2024
Global Follicle Stimulating Hormone FSH ELISA Test Kit Market Research Report 2024
Global Serum Gonadotrophin for Injection Market Research Report 2024
Follitropin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gonadotropin releasing Hormone Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Follicle Stimulating Hormone Test Kit Market Research Report 2024
Gonadotropin releasing Hormone Agonist Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Hormone Market Research Report 2024
Global GnRH Agonist Market Research Report 2024
Global Injectable Reproductive Hormone Market Insights Forecast to 2030
Global Growth Hormone Injection Market Research Report 2024
Global FSH Test Kit Market Research Report 2024
Global Reproductive Hormone Market Insights Forecast to 2030
Luteinizing Hormone releasing Hormone Analogs Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Foetal Skull Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8G20187
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Anatomy Set Pregnancy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30J19782
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Embryo Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-39D19945
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Prostate Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25M19897
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions